Move over Warren Buffett! Amazon CEO Jeff Bezos is now the second richest person on Earth.
The latest tally by Bloomberg’s Billionaires Index shows Bezos is now worth about $75.6 billion. Another ranking compiled by Forbes has Bezos’ value at “just” $75.2 billion.
He added $1.5 billion to his net worth after Amazon (AMZN, Tech30) gained $9 billion in market value during trading hours Wednesday.
The company received a generous stock bump after a Barclay’s (AGRPY) analyst declared Amazon will “likely to be one of the first trillion-dollar market cap companies.” Its shares hit a record high shortly after.
Amazon’s stock has been on fire lately — it’s grown more than 16% over the last year. Investors were pleased with the company’s decision, announced yesterday, to buy Souq, an e-commerce giant in the Middle East.
Amazon isn’t Bezos’s only venture. He also owns space exploration company Blue Origin. Its goal is to eventually take people on “space tourism” trips and to deliver satellites into orbit for corporate climates. So far, the company has only conducted test flights.
Top 10 Warren Buffett Stocks To Own Right Now: NeoGenomics, Inc.(NEO)
Advisors’ Opinion:
- [By Shane Hupp]
NeoGenomics (NASDAQ:NEO) has been given a consensus recommendation of “Buy” by the twelve ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $17.29.
- [By Shane Hupp]
NEO (CURRENCY:NEO) traded up 6.9% against the US dollar during the 24 hour period ending at 7:00 AM Eastern on April 15th. NEO has a total market cap of $4.40 billion and $88.39 million worth of NEO was traded on exchanges in the last day. One NEO coin can now be purchased for about $67.68 or 0.00809123 BTC on popular cryptocurrency exchanges including HitBTC, OKEx, Exrates and Upbit. During the last seven days, NEO has traded up 42.9% against the US dollar.
Top 10 Warren Buffett Stocks To Own Right Now: NIC Inc.(EGOV)
Advisors’ Opinion:
- [By Logan Wallace]
BidaskClub upgraded shares of NIC (NASDAQ:EGOV) from a buy rating to a strong-buy rating in a research note published on Friday morning.
Several other research firms also recently commented on EGOV. Zacks Investment Research downgraded NIC from a hold rating to a sell rating in a report on Monday, January 8th. ValuEngine downgraded NIC from a sell rating to a strong sell rating in a report on Wednesday, May 2nd. Barrington Research restated a hold rating on shares of NIC in a report on Monday, April 30th. TheStreet downgraded NIC from a b- rating to a c rating in a report on Thursday, March 8th. Finally, Loop Capital decreased their price objective on NIC to $14.00 and set a hold rating for the company in a report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, five have issued a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and a consensus target price of $18.33.
Top 10 Warren Buffett Stocks To Own Right Now: VSE Corporation(VSEC)
Advisors’ Opinion:
- [By Max Byerly]
VSE (NASDAQ:VSEC) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Monday.
Top 10 Warren Buffett Stocks To Own Right Now: Rigel Pharmaceuticals Inc.(RIGL)
Advisors’ Opinion:
- [By Dan Caplinger]
Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.
Top 10 Warren Buffett Stocks To Own Right Now: Premier, Inc.(PINC)
Advisors’ Opinion:
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Premier (PINC)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin]
Companies Reporting After The Bell
Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39
Top 10 Warren Buffett Stocks To Own Right Now: Liberty Global plc(LILA)
Advisors’ Opinion:
- [By Logan Wallace]
Dish Network (NASDAQ: DISH) and Liberty Latin America (NASDAQ:LILA) are both consumer discretionary companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.
- [By Ethan Ryder]
Liberty Latin America (NASDAQ:LILA) has been assigned a consensus rating of “Hold” from the ten ratings firms that are covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The average 12 month price objective among brokerages that have issued a report on the stock in the last year is $24.75.
Top 10 Warren Buffett Stocks To Own Right Now: Yuma Energy, Inc.(YUMA)
Advisors’ Opinion:
- [By Lisa Levin]
Breaking news
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) disclosed that it received the FDA approval for Calcium Chloride injection.
Rapid7, Inc. (NASDAQ: RPD) reported a proposed offering of 3 million shares.
Yuma Energy Inc (NYSE: YUMA) reported a Q1 loss of $0.16 per share on sales of $5.646 million. The company also disclosed that it is actively seeking strategic alternatives.
NiSource Inc. (NYSE: NI) disclosed a 24.96 million share common stock offering via selling holders. - [By Lisa Levin]
Shares of Yuma Energy, Inc. (NYSE: YUMA) were down 60 percent to $0.4520 after the company late Friday reported it was not in compliance with its debt to EBITDAX covenant and announced limited liquidity levels. The company also reported Q1 earnings down year-over-year and disclosed that it is exploring strategic alternatives.
Top 10 Warren Buffett Stocks To Own Right Now: Gilead Sciences, Inc.(GILD)
Advisors’ Opinion:
- [By George Budwell]
When it comes to biotech stocks, Celgene(NASDAQ:CELG) and Gilead Sciences (NASDAQ:GILD) are easily two of the brightest stars. After all, these two top dogs have generated enormous returns for investors since the start of the biotech bull market back in 2010:
- [By Chris Lange]
The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Gilead Sciences, Inc. (NASDAQ: GILD) which rose about 4% to $88.78. The stocks 52-week range is $63.76 to $89.54. Volume was roughly 18 million compared to the daily average volume of about 8 million.
- [By George Budwell]
After releasing downright worrisome first-quarter results, Gilead Sciences (NASDAQ:GILD) has seen its shares drop by a noteworthy 11.7% in the past few days. The big concern is that Gilead’s ailing hepatitis C franchise has yet to stabilize in the wake of newfound competition from AbbVie’s (NYSE:ABBV)Mavyret.
- [By Keith Speights]
AbbVie’s new hepatitis C virus (HCV) drug Mavyretappears to be giving Gilead Sciences (NASDAQ:GILD) a run for its money. In the first quarter, AbbVie’s net HCV revenue came in at $919 million. That total includes both of the company’s HCV drugs, Viekira and Mavyret. But there’s virtually no question that Mavyret is contributing most of AbbVie’s HCV revenue.
- [By ]
Booker’s report took on other companies as well. Pfizer (PFE) , Gilead Sciences (GILD) , AbbVie (ABBV) , Amgen (AMGN) , Bristol-Myers Squibb (BMY) Eli Lilly & Co. (LLY) , and Mylan NV (MYL) are cited for everything from raising drug prices, to stock buybacks and putting shareholder interest before that of the public.
Top 10 Warren Buffett Stocks To Own Right Now: QuinStreet, Inc.(QNST)
Advisors’ Opinion:
- [By Dan Caplinger]
The mood was negative on Wall Street on Wednesday, and most major benchmarks finished in the red. Strength in the technology sector wasn’t enough to lift more cyclically focused benchmarks like the Dow Jones Industrial Average, and the combination of an attack on Saudi Arabia that sent oil prices higher and some disquieting readings on the inflation front kept investors from feeling more confident about stocks going into earnings season. In addition, some individual companies had bad news that sent their shares lower. Analogic (NASDAQ:ALOG), QuinStreet (NASDAQ:QNST), and MSC Industrial Direct (NYSE:MSM) were among the worst performers on the day. Here’s why they did so poorly.
Top 10 Warren Buffett Stocks To Own Right Now: bluebird bio, Inc.(BLUE)
Advisors’ Opinion:
- [By Ethan Ryder]
Blue Protocol (CURRENCY:BLUE) traded down 9.1% against the U.S. dollar during the 24-hour period ending at 11:00 AM Eastern on May 12th. One Blue Protocol token can now be purchased for about $0.18 or 0.00002166 BTC on cryptocurrency exchanges including CoinExchange, EtherDelta (ForkDelta), IDEX and YoBit. In the last seven days, Blue Protocol has traded down 16.3% against the U.S. dollar. Blue Protocol has a market capitalization of $6.65 million and $31,443.00 worth of Blue Protocol was traded on exchanges in the last 24 hours.
- [By Keith Speights]
Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?
- [By Todd Campbell, Leo Sun, and Daniel Miller]
For instance, the company recently acquired Juno Therapeutics to get its hands on a pipeline of chimeric antigen receptor T-cell gene therapies (CAR-Ts). CAR-Ts represent one of the biggest recent advances in treating blood cancer, and depending on trial results, the first CAR-T from this collaboration could be filed for approval next year. Similarly, Celgene is partnering with bluebird bio (NASDAQ:BLUE) on bb2121, a CAR-T for multiple myeloma. So far, bb2121 is delivering 90%-plus response rates in heavily pre-treated patients, and if that success continues, it could end up on regulators’ desk for approval next year, too.
- [By Rafi Farber]
Heres some perspective. Within the past decade, University of Pennsylvania has allied with Novartis A.G. (NYSE: NVS), Baylor College of Medicine with Bluebird Bio Inc. (NASDAQ: BLUE) and Celgene Corp. (NASDAQ:CELG), Memorial Sloan Kettering Cancer Center and the Fred Hutchinson Cancer Research Center with Juno Therapeutics Inc. (NASDAQ: JUNO) (which Celgene just got clearance to acquire), and the National Cancer Institute with Kite Pharma, which was acquired last year byGilead Sciences Inc. (NASDAQ: GILD).
